QT
VIR icon

Quantamental Technologies’s Vir Biotechnology VIR Stock Holding History

Quantamental Technologies’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$174K Buy
18,519
+6,883
+59% +$98.2K 0.16% 230
2023
Q2 		$285K Buy
11,636
+2,573
+28% +$64.6K 0.12% 293
2023
Q1 		$211K Buy
+9,063
New +$232K 0.11% 330

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantamental Technologies's VIR Position: Q3 2023 in Review

Quantamental Technologies increased its Vir Biotechnology (VIR) stake by 59% in Q3 2023, buying an estimated $98.2K and bringing the position to 18,519 shares worth $174K. The position accounts for 0.16% of the portfolio, ranked #230.

Quantamental Technologies first reported a position in VIR in Q1 2023 and has held it in 3 quarters since. The position peaked at $285K in Q2 2023. 214 funds tracked by Wall St. Rank hold VIR as of Q3 2023.

  • Quantamental Technologies held 18,519 shares of Vir Biotechnology worth $174K as of Q3 2023.
  • Quantamental Technologies bought 6,883 Vir Biotechnology shares in Q3 2023, an estimated $98.2K.
  • Vir Biotechnology made up 0.16% of Quantamental Technologies's portfolio in Q3 2023, its #230 holding.
  • Quantamental Technologies first reported a position in Vir Biotechnology in Q1 2023 and has held it in 3 quarters since.
  • Quantamental Technologies's Vir Biotechnology position peaked at $285K in Q2 2023.
  • 214 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.